Open platforms are the future
The OPEN-SCS Group was initiated in 2014 to define, publish and maintain an OPC UA based standard and companion documents for the integration of serialization solutions. Syntegon fully supports the mission statement of the working group, to “allow functional interoperability of serialization solutions in order to seamlessly integrate the operations and business processes across organizations and regulatory bodies, aligning with other industry groups and standards whenever appropriate.”
“Apart from the fact that saving lives through anti-counterfeiting measures is an excellent reason to joint OPEN-SCS, we also firmly believe in open digital worlds and open platforms”, says Jörg Willburger, product manager for Track & Trace systems at Syntegon. “Customers should have no constraints and a high flexibility to choose. Mixed systems with machines and software from different suppliers, combined with common interfaces will become standard. And that’s exactly what we want to achieve with our commitment in OPEN-SCS.”
Syntegon will contribute to the success of OPEN-SCS with long-standing experience in Track & Trace and serialization solutions, as Jörg Willburger explains. “We know that successful serialization projects usually consist of many different applications. In the end, it’s all about having the right interfaces to combine them – and to realize the individual solution for each customer”, he says. Picture: Syntegon
Syntegon, formerly Bosch Packaging Technology, not only manufactures machines and equipment for serialization. It also offers the corresponding software, Manufacturing Execution Systems (MES), line management and master data solutions, as well as a comprehensive Industry 4.0 portfolio.
“Win-win for everyone”
At OPEN-SCS, Marketing Director Thomas Halfmann is delighted that Syntegon has joined the working group: “All members are looking forward to working with Syntegon and to realizing our targets together.” Apart from suppliers of machines and software solutions, the group also includes consulting and pharmaceutical companies. “It really is a win-win for everyone”, Halfmann and Willburger agree.